Search for: "Mylan Pharmaceuticals"
Results 661 - 680
of 739
Sort by Relevance
|
Sort by Date
28 Jul 2008, 9:31 pm
The medicine also known as Digoxin, is distributed by Mylan Pharmaceuticals, according to this news report. [read post]
28 Jul 2008, 7:01 pm
Mylan Laboratories, Inc., 520 F.3d 1358, 1364 (Fed. [read post]
28 Jul 2008, 10:36 am
Both Mylan Pharmaceuticals and UDL are owned by parent company Mylan, a drug company based in Pittsburgh, Pennsylvania with a market cap of $4 billion. [read post]
25 Jul 2008, 11:56 pm
Digitek is distributed by Mylan Pharmaceuticals, Inc. under a "Bertek" label and by UDL Laboratories, Inc. under a "UDL" label.The voluntary recall of the Digitek tablets manufactured at the New Jersey Actavis facility occurred because tablets may have been commercially released in the U.S. market with double the thickness of the normal sized tablets. [read post]
25 Jul 2008, 7:04 am
, (Daily Dose of IP), 26 August: WIPO symposium on IP and multilateral agreements – Geneva: (IPKat), 11-12 September: US LSI: 4th annual conference on ‘Current issues in complex IP licensing’ – Philadelphia: (Patent Docs), 11 September/15 October: PLI seminar on developments in pharmaceutical and biotech patent law – New York/San Francisco: (Patent Docs), 15-16 September: UniForum & SAIIPL domain name ADR workshop –… [read post]
25 Jul 2008, 2:11 am
Mylan Laboratories, Inc., 520 F.3d 1358, 1364 (Fed. [read post]
24 Jul 2008, 5:15 pm
The product is made by Totowa LLC and distributed by Mylan Pharmaceuticals Inc., under a “Bertek” label and by UDL Laboratories, Inc., under a “UDL” label. [read post]
15 Jul 2008, 4:33 pm
We start with the recent allegations being made against the Indian pharmaceutical giant Ranbaxy Laboratories, which manufactures drugs at 11 sites around the globe and had global sales of $1.6 billion last year. [read post]
11 Jul 2008, 4:30 am
, (Daily Dose of IP), 11-12 September: US LSI: 4th annual conference on ‘Current issues in complex IP licensing’ – Philadelphia: (Patent Docs), 11 September/15 October: PLI seminar on developments in pharmaceutical and biotech patent law – New York/San Francisco: (Patent Docs), 15-16 September: UniForum & SAIIPL domain name ADR workshop – Centurion (South Africa): (Afro-IP), 15-16 September: US ACI 10th advanced forum on biotech… [read post]
5 Jul 2008, 11:05 am
, (Daily Dose of IP), 11-12 September: US LSI: 4th annual conference on ‘Current issues in complex IP licensing’ – Philadelphia: (Patent Docs), 11 September/15 October: PLI seminar on developments in pharmaceutical and biotech patent law – New York/San Francisco: (Patent Docs), 15-16 September: UniForum & SAIIPL domain name ADR workshop – Centurion (South Africa): (Afro-IP), 15-16 September: US ACI 10th advanced forum on biotech… [read post]
27 Jun 2008, 10:04 am
: (The Invent Blog), Impressive work on history of ‘Happy Birthday’ and copyright protection: (Innovationpartners), Gender and copyright: (Patry Copyright Blog) Events 1 July: US PLI: ‘Prior art & obviousness 2008: The PTO and CAFC perspective on patent law sections 102 & 103’ - New York: (Patent Docs), 1-2 July – C5 conference on intellectual asset management for high-tech industries – Paris: (c5-online.com), 2… [read post]
27 Jun 2008, 6:35 am
Barr Pharmaceuticals Inc. and Mylan Inc. invalidated a patent (4,886,812) of Boehringer Ingelheim on Mirapex in D. [read post]
26 Jun 2008, 6:31 pm
., Mylan Laboratories, Inc., v. [read post]
25 Jun 2008, 4:13 pm
The manufacturer and distributor of the defective drug include Actavis Totowa, Mylan Pharmaceuticals, Bertek, and UDL Laboratories. [read post]
23 Jun 2008, 11:55 am
The products are distributed by Mylan Pharmaceuticals, Inc. under a "Bertek" label and by UDL Laboratories, Inc. under a "UDL" label. [read post]
20 Jun 2008, 6:13 pm
The products are distributed by Mylan Pharmaceuticals Inc., under a "Bertek" label and by UDL Laboratories, Inc. under a "UDL" label. [read post]
20 Jun 2008, 8:07 am
: (Spicy IP), Latin America: Merck Serono signs distribution agreement with Bristol-Myers Squibb for portfolio of established pharmaceutical brands in Latin America: (IP tango), US: Biotech industry growth to slow due to funding pressures and competition from biosimilars: (Managing Intellectual Property), US: House Commerce Committee posts responses to its questions on biogenerics; not surprisingly, the views run the gamut: (FDA Law Blog), US: Biosimilar debate heats up at BIO: (Managing… [read post]
13 Jun 2008, 3:40 am
: (Patent Docs), Generic drug developers will continue to take advantage of global demand for lower-priced drugs, with Teva poised to maintain lead position says Goldman Sachs analyst: (GenericsWeb), Daiichi Sankyo takeover of Ranbaxy: (Profitability through Simplicity), (Spicy IP), (GenericsWeb), Canada: Generics to penetrate 26% pharma market in Canada says RNCOS research: (GenericsWeb), Canada: Generic drug makers spreading misinformation about patent regulation amendments to dodge real story:… [read post]
12 Jun 2008, 9:35 pm
Generic drug maker Mylan got some good news from the U.S. [read post]
12 Jun 2008, 4:45 am
By Donald Zuhn -- Yesterday, the Federal Circuit affirmed the determination by the District Court for the Southern District of New York that Defendants-Appellees Mylan Laboratories, Inc., Mylan Pharmaceuticals, Incorporated, Esteve Quimica, S.A., and Laboratorios Dr. [read post]
